Literature DB >> 19850751

Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease.

Michael Stadler, Renate Ahlborn, Haytham Kamal, Helmut Diedrich, Stefanie Buchholz, Matthias Eder, Arnold Ganser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19850751     DOI： 10.1182/blood-2009-07-231159

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  14 in total

1.  A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.

Authors:  Sabarinath Venniyil Radhakrishnan; Gerhard C Hildebrandt
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

Review 2.  Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials.

Authors:  Naoki Iwamoto; Jörg H W Distler; Oliver Distler
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

3.  Imatinib for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  S Watanabe; Y Waseda; H Kimura; H Takato; K Ohata; Y Kondo; K Kasahara; S Nakao
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

Review 4.  Treatment of chronic graft-versus-host disease in 2011.

Authors:  Yoshihiro Inamoto; Mary E D Flowers
Journal:  Curr Opin Hematol       Date:  2011-11       Impact factor: 3.284

Review 5.  State-of-the-art acute and chronic GVHD treatment.

Authors:  Muhammad Omer Jamil; Shin Mineishi
Journal:  Int J Hematol       Date:  2015-04-12       Impact factor: 2.490

Review 6.  Treatment and management of graft-versus-host disease: improving response and survival.

Authors:  Catherine Garnett; Jane F Apperley; Jiří Pavlů
Journal:  Ther Adv Hematol       Date:  2013-12

7.  Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.

Authors:  Kristin Baird; Leora E Comis; Galen O Joe; Seth M Steinberg; Fran T Hakim; Jeremy J Rose; Sandra A Mitchell; Steven Z Pavletic; William D Figg; Lawrence Yao; Kathleen C Flanders; Naoko Takebe; Stefanie Sarantopoulos; Susan Booher; Edward W Cowen
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-12       Impact factor: 5.742

8.  Development of severe sclerotic chronic GVHD during treatment with dasatinib.

Authors:  D Pulanic; E W Cowen; K Baird; M R Bishop; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

Review 9.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

Review 10.  Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside.

Authors:  Jacopo Olivieri; Sabrina Coluzzi; Imma Attolico; Attilio Olivieri
Journal:  ScientificWorldJournal       Date:  2011-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.